A novel workflow for cancer blood biomarker identification

BACKGROUND: Over the last few years, great progress has been made in the development of key technologies to detect peripheral blood-based, tumor-specific biomarkers, such as circulating tumor cells (CTCs) and circulating cell free tumor DNA (ctDNA). Despite the considerable advances and their multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiang, Qiu, Zhiqiang, Ji, Xiangwen, Ning, Weihai, An, Yihua, Wang, Shengdian, Zhang, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723582/
https://www.ncbi.nlm.nih.gov/pubmed/33313175
http://dx.doi.org/10.21037/atm-20-2047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723582/
https://www.ncbi.nlm.nih.gov/pubmed/33313175
http://dx.doi.org/10.21037/atm-20-2047

Ejemplares similares